MSB 1.02% 99.0¢ mesoblast limited

Where is Novartis?, page-116

  1. 15,402 Posts.
    lightbulb Created with Sketch. 5514
    There are cheaper alternatives now and more will be fast tracked.

    You have been saying this for months and yet the USA death numbers have remained stagnant at around 5,000+ per week for the last 3+ months .... what they are using now is not working to further reduce the weekly death toll now that it has plateaued and I haven't seen any magical new treatments of late that are having success ? In fact the FDA just rejected another treatment that everyone touted was cheaper and supposedly better than Remestemcel-L, but you already knew that

    https://www.fda.gov/drugs/drug-safety-and-availability/statement-leronlimab



    That’s why no one is talking about stems as a treatment.

    Funniest comment I have seen on HC year to date - just sayin' ... 'no one' .... LMAO ... here is some examples ..... as for the rest of your post - enough said

    https://www.news-medical.net/news/2...e-the-outcome-of-ARDS-in-severe-COVID-19.aspx


    https://www.news-medical.net/news/20210505/Stem-cell-therapy-for-COVID-19-and-ARDS.aspx


    https://www.galvnews.com/news_ap/business/article_c896db0b-cc8c-56b3-84d5-9c302e0d568f.html


    https://www.nature.com/articles/s41536-020-00105-z


    https://www.news-medical.net/news/2...e-the-outcome-of-ARDS-in-severe-COVID-19.aspx


    https://www.biospace.com/article/umbilical-cord-stem-cells-show-promise-as-covid-19-therapy/
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.010(1.02%)
Mkt cap ! $1.130B
Open High Low Value Volume
99.5¢ $1.02 98.5¢ $5.507M 5.501M

Buyers (Bids)

No. Vol. Price($)
1 9996 99.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.5¢ 18069 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.